Closed Loop Medicine (CLM) has appointed Kate Woolland as Chief Executive Officer. Previously serving as Chief Operating ...

Moderna has reported positive phase 3 results for its seasonal flu vaccine, mRNA-1010, which outperformed a standard-dose ...

UCB has announced that its phase 3 trial evaluating fenfluramine in CDKL5 deficiency disorder (CDD) achieved its primary and ...

New data show strong efficacy of CD388 in phase 2b trial Cidara Therapeutics and hVIVO have announced encouraging topline results from a global phase 2b field study evaluating CD388, a drug-Fc ...

Why supporting representative trial participation matters ...

CLEO Systems is also part of the NHS Pathfinder pilot programme with around 200 community pharmacies in England, further ...

eXmoor Pharma and Signadori Bio have entered into a partnership aimed at advancing a gene-modified monocyte-derived ...

As sure as night follows day, the International Clinical Researcher of the Year Awards returned for another special evening ...

These indicators, known as ‘biomarkers’ – which include proteins, chemicals and other molecules that indicate normal or ...

Teva’s experimental anti-PD1-IL2 ATTENUKINE therapy is designed to selectively deliver interleukin-2 to PD-1-expressing T ...

This year’s NHS ConfedExpo took place on 11–12 June at Manchester Central, bringing together around 9000 attendees. Among ...

VectorY Therapeutics has appointed Jessica Atkinson as Chief Business Officer. In this newly created role, she will support ...